Regulatory Affairs Strategy Meeting East Coast 2023

The relentless evolution of bacterial resistance has rendered many conventional antibiotics ineffective, pushing researchers toward unconventional therapeutic strategies.

Unlike traditional small-molecule drugs, which interact with proteins, RNA therapies modulate gene expression directly, enabling interventions at the root of disease.

Managing inventory in the biotech and pharmaceutical industries is uniquely complex due to demand substitution.

The transition from fossil to biomass feedstocks represents more than substitution—it’s a fundamental reimagining of chemical manufacturing’s first principles.

Automation simplifies workflows and enables new experiments with mass spec’s unmatched specificity.

What began as a clever repurposing of Drosophila biology has matured into a platform technology transforming how therapeutic proteins are discovered, optimized, and manufactured.

Bioreactors serve as the cornerstone of modern bioprocessing, enabling the scalable production of therapeutics, biofuels, and engineered tissues.

Unlike bulk pharmaceutical manufacturing with its predictable campaigns, early-stage drug discovery operates in a landscape of radical uncertainty.